Michael Krams, M.D., Joins Exscientia as Chief Quantitative Medicine Officer
Exscientia plc (Nasdaq: EXAI) today announced the appointment of Michael Krams, M.D., as its Chief Quantitative Medicine Officer. In this newly created role, Dr. Krams will lead clinical development
Source: finanznachrichten.de